These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 2839627

  • 21. Diuretics potentiate angiotensin converting enzyme inhibitor-induced acute renal failure.
    Mandal AK, Markert RJ, Saklayen MG, Mankus RA, Yokokawa K.
    Clin Nephrol; 1994 Sep; 42(3):170-4. PubMed ID: 7994935
    [Abstract] [Full Text] [Related]

  • 22. The effects of thiazide and thiazide-potassium sparing diuretics on fibrinolytic system parameters.
    Kaşifoğlu T, Yalçin AU.
    Anadolu Kardiyol Derg; 2006 Jun; 6(2):143-7. PubMed ID: 16766279
    [Abstract] [Full Text] [Related]

  • 23. [Efficacy and tolerability of enalapril compared to altizide combined with spironolactone in patients with moderate arterial hypertension].
    Gibelin P, Durand P, Baudouy M, Camous JP, Morand P.
    Ann Cardiol Angeiol (Paris); 1986 May; 35(5):279-83. PubMed ID: 3019212
    [Abstract] [Full Text] [Related]

  • 24. Clinical experience with converting-enzyme inhibitors in hypertension.
    Weber MA.
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):45-51. PubMed ID: 3037889
    [Abstract] [Full Text] [Related]

  • 25. Effects of angiotensin converting enzyme inhibitor on renal function in patients of membranoproliferative glomerulonephritis with mild to moderate renal insufficiency.
    Giri S, Mahajan SK, Sen R, Sharma A.
    J Assoc Physicians India; 2002 Oct; 50():1245-9. PubMed ID: 12568207
    [Abstract] [Full Text] [Related]

  • 26. Influence of combined angiotensin-converting enzyme inhibitors and spironolactone on serum K+, Mg 2+, and Na+ concentrations in small dogs with degenerative mitral valve disease.
    Thomason JD, Rockwell JE, Fallaw TK, Calvert CA.
    J Vet Cardiol; 2007 Nov; 9(2):103-8. PubMed ID: 17983885
    [Abstract] [Full Text] [Related]

  • 27. Renal effects of angiotensin-converting enzyme inhibition in cardiac failure.
    Dzau VJ.
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):74-80. PubMed ID: 3037893
    [Abstract] [Full Text] [Related]

  • 28. Hypokalemia during the treatment of arterial hypertension with diuretics.
    Lemieux G, Beauchemin M, Vinay P, Gougoux A.
    Can Med Assoc J; 1980 Apr 19; 122(8):905-7. PubMed ID: 7370875
    [Abstract] [Full Text] [Related]

  • 29. [Severe electrolyte disorders during the therapy of heart failure with the therapy of heart failure with the ACE-inhibitor enalapril].
    Hess B, Keusch G, Neftel K, Margelist F, Bansky G.
    Schweiz Med Wochenschr; 1986 Sep 27; 116(39):1331-6. PubMed ID: 3022372
    [Abstract] [Full Text] [Related]

  • 30. Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned?
    Erman A, Boner G, van Dijk DJ.
    J Renin Angiotensin Aldosterone Syst; 2000 Dec 27; 1(4):365-8. PubMed ID: 11967825
    [Abstract] [Full Text] [Related]

  • 31. Study of the use of a spironolactone and angiotensin-converting enzyme inhibitor combination: a population-based analysis.
    Besançon JF, Lagarce L, Diquet B, Lainé-Cessac P.
    Pharmacoepidemiol Drug Saf; 2008 Feb 27; 17(2):172-9. PubMed ID: 17948926
    [Abstract] [Full Text] [Related]

  • 32. Enalapril, a nonsulfhydryl angiotensin-converting enzyme inhibitor.
    Vlasses PH, Larijani GE, Conner DP, Ferguson RK.
    Clin Pharm; 1985 Feb 27; 4(1):27-40. PubMed ID: 2982541
    [Abstract] [Full Text] [Related]

  • 33. Hypertension in a patient with hypercalcemia: captopril and verapamil.
    Waeber B, Brunner HR, Burckhardt P, Gavras H.
    Arch Intern Med; 1982 Jan 27; 142(1):143-5. PubMed ID: 7032443
    [Abstract] [Full Text] [Related]

  • 34. Laboratory evaluation of potassium and creatinine among ambulatory patients prescribed spironolactone: are we monitoring for hyperkalemia?
    Raebel MA, McClure DL, Chan KA, Simon SR, Feldstein AC, Lafata JE, Andrade SE, Gunter MJ, Nelson WW, Roblin D, Platt R.
    Ann Pharmacother; 2007 Feb 27; 41(2):193-200. PubMed ID: 17284506
    [Abstract] [Full Text] [Related]

  • 35. [Potassium-sparing diuretics (spironolactone, triamterene, amylorid)].
    Haris A, Radó J.
    Orv Hetil; 1996 Sep 01; 137(35):1907-14. PubMed ID: 8927344
    [Abstract] [Full Text] [Related]

  • 36. Aldosterone antagonism in addition to angiotensin-converting enzyme inhibitors in heart failure.
    Bauersachs J, Fraccarollo D.
    Minerva Cardioangiol; 2003 Apr 01; 51(2):155-64. PubMed ID: 12783071
    [Abstract] [Full Text] [Related]

  • 37. Enalapril treatment in a patient with impaired renal function and intolerance to captopril.
    Lindsjö M, Danielson BG, Weiss L, Wikström B.
    Scand J Urol Nephrol Suppl; 1984 Apr 01; 79():99-101. PubMed ID: 6089326
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers.
    Raebel MA, McClure DL, Simon SR, Chan KA, Feldstein A, Andrade SE, Lafata JE, Roblin D, Davis RL, Gunter MJ, Platt R.
    Pharmacoepidemiol Drug Saf; 2007 Jan 01; 16(1):55-64. PubMed ID: 16470693
    [Abstract] [Full Text] [Related]

  • 40. [Effects of angiotensin-converting enzyme inhibitors in hypertension].
    Rahn KH.
    Z Kardiol; 1988 Jan 01; 77 Suppl 3():69-71. PubMed ID: 2850690
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.